Riskpilot← Back to searchSign inGet full accessMikael Sköldenklint AB
ABActiveOrg 5569738239Stensövägen 91Dental practice care activities · NACE 8623Est. 20140 employees
Revenue 2025
SEK 0
EBITDA margin
—
-142% vs 2024
Equity ratio
93.1%
Financial strength
Net profit 2025
SEK 0
-100% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -29K | -142% |
| Net profit | SEK 0 | -100% |
| Total assets | SEK 16M | -5% |
| Equity | SEK 14,9M | -9% |
| Employees | 0 | — |
Legal name
Mikael Sköldenklint AB
Org number
5569738239
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
5 juni 2014
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-05-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva förvaltning av dotterbolagsaktier samt därmed förenlig verksamhet.
Address
Stensövägen 91
Email
mikaelskoldenklint1@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −39 | −1 | −1 | −12 | −29 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −39 | −1 | −1 | −12 | −29 |
| Net financials | — | 3 000 | 7 000 | 4 002 | −116 |
| Profit before tax | −39 | 2 998 | 7 040 | 3 991 | 13 |
| Tax | −0 | −0 | −0 | −0 | −13 |
| Net profit | −39 | 2 998 | 7 040 | 3 991 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 055 | 7 653 | 14 352 | 16 803 | 15 983 |
| Equity | 6 704 | 7 302 | 14 342 | 16 383 | 14 883 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 351 | 351 | 10 | 420 | 1 100 |
| Total debt | 351 | 351 | 10 | 420 | 1 100 |
EBITDA margin
-2900000.0%
This company
15.8%
Market median
-18354530% vs market
20212025
Equity ratio
93.1%
This company
38.2%
Market median
+144% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-06-01 – 2025-05-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-06-01 – 2024-05-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-06-01 – 2023-05-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-06-01 – 2022-05-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-06-01 – 2021-05-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MR Chief Auditor | Chief Auditor | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mikael Sköldenklint AB 
Tandläkare Sköldenklint ABBoard members of Mikael Sköldenklint AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Robert Björklund | Chief Auditor | 0 companies |
| Mikael Eric Sköldenklint | Board of Directors | 0 companies |
| Per Erik Torsten Sköldenklint | Deputy Board Member | 0 companies |